Early evidence and clinical experience suggest they may be powerful adjuncts for recovery, longevity, and optimization helping patients heal faster, age gracefully, and perform at their best.
The GLP-1 drug participants had no progression of motor symptoms (-0.04), and the 3.04 worsening in the placebo group (difference between the two arms=3.08) is just short of what is considered clinically meaningful (3.5)
The claim
Diabetol Metab Syndr 14(1):12 Bogner HR, Morales KH, de Vries HF, Cappola AR (2012) Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial
however, to date, nothing has carried on into clinical practice. There is a wide range of obesity medications under investigation with different physiologic targets
Science 286 , 711715 (1999)